In vitro hæmmer imatinib proliferationen og inducerer apoptose i GIST- tumorcellerne, som udtrykker kit- mutationen.
In vitro, imatinib inhibits proliferation and induces apoptosis in gastrointestinal stromal tumour (GIST) cells, which express an activating kit mutation.